Wei Liang
Senior Scientist, Computational Toxicology Abbvie
Dr. Wei Liang holds a Ph.D. in Computational Neuroscience from the University of Chicago and is currently a Senior Research Scientist in Computational Toxicology at AbbVie. With a highly interdisciplinary approach, she leverages cutting-edge machine learning techniques to address complex biological and toxicological challenges. Dr. Liang’s expertise spans computational modeling for target safety assessments, the evaluation of compounds across diverse modalities, and the integration of computer vision to enhance animal behavior analysis for safety and efficacy studies. Her innovative work bridges computer science and biology, contributing impactful solutions that advance pharmaceutical research and development.
Seminars
- Landscape of in silico models for small molecules and larger molecules where limited clinical and preclinical datasets hinder model accuracy and validation
- New data integration and modelling approaches with knowledge graph and generative models for connecting heterogenous datasets and modelling animal variabilities
- Explore how to evaluate combination therapy safety by modelling target pathway interactions dose considerations and additive or offsetting toxicity risks to support more confident regulatory acceptance
